Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

5,832

Participants

Timeline

Start Date

June 3, 2019

Primary Completion Date

January 11, 2027

Study Completion Date

January 11, 2027

Conditions
Tuberculosis, MDR
Interventions
DRUG

Delamanid (DLM)

"Adults and children ≥30 kg: delamanid 200 mg orally once daily.~Children ≥2.5 kg to \<30 kg: weight-band dosing orally once daily as per the study protocol. As children gain weight, their DLM dose should be adjusted, typically every month or as the visit schedule permits."

DRUG

Isoniazid (INH)

"Adults and children ≥24 kg: INH 300 mg orally once daily.~Children ≥2.5 kg to \<24 kg: INH weight-band dosing orally once daily as per the study protocol. As children gain weight, their INH dose should be adjusted."

DIETARY_SUPPLEMENT

Pyridoxine (vitamin B6)

All HHCs in Arm B must receive pyridoxine (vitamin B6) with each dose of INH based on the current local dosing guidelines. For children up to 3 years of age and nursing women, pyridoxine will be given as per local standard of care. Pyridoxine is not supplied through the study.

Trial Locations (31)

1862

Soweto ACTG CRS, Johannesburg

2092

Wits Helen Joseph Hospital CRS (Wits HJH CRS), Johannesburg

2574

PHRU Matlosana CRS, Klerksdorp

4001

CAPRISA eThekwini CRS, Durban

4052

Durban International Clinical Research Site CRS, Durban

4114

De La Salle Health Science Institute Angelo King Medical Research Center (DLSHSI-AKMRC), Cavite

7505

Desmond Tutu TB Centre - Stellenbosch University (DTTC-SU) CRS, Cape Town

7530

Task Applied Science (TASK) CRS, Cape Town

7700

University of Cape Town Lung Institute (UCTLI) CRS, Cape Town

7705

South African Tuberculosis Vaccine Initiative (SATVI) CRS, Cape Town

10330

Thai Red Cross AIDS Research Centre (TRC-ARC) CRS, Pathum Wan

10700

Siriraj Hospital ,Mahidol University NICHD CRS, Bangkok

15001

Socios En Salud Sucursal Perú CRS, Lima

15063

Barranco CRS, Lima

20200

Kenya Medical Research Institute/Walter Reed Project Clinical Research Center (KEMRI/WRP) CRS, Kericho

30100

Moi University Clinical Research Center (MUCRC) CRS, Eldoret

50100

Chiangrai Prachanukroh Hospital NICHD CRS, Chiang Mai

70000

Vietnam-University of Sydney CRS Site# 32495, Hochiminh City

100000

National Lung Hospital CRS (Site ID: 32483), Vĩnh Phúc

411001

Byramjee Jeejeebhoy Medical College (BJMC) CRS, Pune

600010

YRG CARE CRS [Site ID: 32075], Chennai

Unknown

Gaborone CRS, Gaborone

Kilimanjaro Christian Medical Centre (KCMC), Moshi

Joint Clinical Research Centre (JCRC)/Kampala Clinical Research Site, Kampala

MU-JHU Research Collaboration (MUJHU CARE LTD) CRS, Kampala

Milton Park CRS, Milton Park

21040-360

Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS, Rio de Janeiro

HT-6110

GHESKIO Institute of Infectious Diseases and Reproductive Health (GHESKIO - IMIS) CRS, Port-au-Prince

Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS, Port-au-Prince

32-15088

San Miguel CRS, Lima

0300

Rustenburg CRS, Rustenburg

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT03568383 - Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients | Biotech Hunter | Biotech Hunter